Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
OPKO Health (OPK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 penny stocks outperforming Facebook Meta stock today The post 4 Penny Stocks To Buy For Under $5 Outperforming FB Stock In 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | P

OPKO Health rises 5% as CEO & Chairman buys 1.5M shares

06:40pm, Thursday, 03'rd Feb 2022 Seeking Alpha
OPKO Health <> trades higher following the company''s CEO & Chairman bought 150,000 shares at $2.99 - $3.05 worth ~ $460K.

Opko Health''s partner launches Rayaldee in Germany

06:29pm, Thursday, 03'rd Feb 2022 Seeking Alpha
Opko Health (OPK) said Vifor Fresenius Medical Care Renal Pharma launched Rayaldee (extended release calcifediol) in Germany.Rayaldee extended-release capsules are indicated for…
4 penny stocks outperforming Facebook Meta stock today The post 4 Penny Stocks To Buy For Under $5 Outperforming FB Stock In 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | P

How Concerning Is Pfizer and Opko's Latest FDA Rejection?

11:55am, Thursday, 03'rd Feb 2022 The Motley Fool
It depends on exactly why the FDA decided not to approve the two companies' growth hormone therapy.

OPKO Health (OPK) Stock Sinks As Market Gains: What You Should Know

11:15pm, Wednesday, 02'nd Feb 2022 Zacks Investment Research
OPKO Health (OPK) closed at $3.04 in the latest trading session, marking a -0.65% move from the prior day.
OPKO Health (OPK) closed at $3.04 in the latest trading session, marking a -0.65% move from the prior day.

Pfizer (PFE) Ends Vupanorsen Development, Returns Rights to Ionis

04:43pm, Tuesday, 01'st Feb 2022 Zacks Investment Research
Pfizer (PFE) returns development rights to Ionis for the investigational antisense therapy, vupanorsen.

OPKO Health (OPK) Dips More Than Broader Markets: What You Should Know

11:15pm, Thursday, 27'th Jan 2022 Zacks Investment Research
OPKO Health (OPK) closed at $2.87 in the latest trading session, marking a -1.37% move from the prior day.

Why Opko Health Stock Is Crashing This Week

10:33pm, Thursday, 27'th Jan 2022 The Motley Fool
The FDA refused to approve human growth hormone somatrogon.

Why Opko Health Stock Is Crashing This Week

05:33pm, Thursday, 27'th Jan 2022
The FDA refused to approve human growth hormone somatrogon.

Biotech Stock Roundup: VRTX Q4 Earnings, GILD, INCYs Regulatory Updates & More

03:27pm, Thursday, 27'th Jan 2022 Zacks Investment Research
Earnings updates from Vertex (VRTX) and pipeline updates are among a few key highlights from the biotech sector during the past week.
EV stocks provided a microcosm of market volatility on Monday. Meanwhile, KSS rallied on takeover chatter. PGR hit a fresh high. SNAP set a new low. OPK plunged on an FDA decision.

Why Opko Health Stock Is Off 23% Today

07:06pm, Monday, 24'th Jan 2022 The Motley Fool
The market was counting on a key drug approval that suddenly appears unlikely to happen.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE